The final guidance explains some principles for developing biosimilars and establishes some rules about extrapolation across indications for various medical conditions. EMA released final guidance on ...
Survival extrapolation plays a pivotal role in cost-effectiveness analysis by extending observed clinical trial data to estimate long-term patient outcomes. Given that the follow‐up periods of trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback